Status:
COMPLETED
Swaziland Safe Generations
Lead Sponsor:
Columbia University
Collaborating Sponsors:
United States Agency for International Development (USAID)
Ministry of Health, Swaziland
Conditions:
HIV/AIDS
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to understand how best to provide care and treatment services to human immunodeficiency virus (HIV) positive pregnant women and their babies in Swaziland. The study is des...
Detailed Description
Purpose: "Situkulwane Lesiphephile-Safe Generations" is an implementation science research study designed to evaluate an innovative PMTCT strategy that includes a modified Option B approach, where al...
Eligibility Criteria
Inclusion
- Women at least 18 years of age
- Documented pregnancy (per routine ANC protocol in this setting)
- Documented HIV-infection (per routine ANC protocol in this setting)
- Infants born to eligible and enrolled women
Exclusion
- • Women already on ART when entering ANC
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2016
Estimated Enrollment :
2518 Patients enrolled
Trial Details
Trial ID
NCT01891799
Start Date
August 1 2013
End Date
October 30 2016
Last Update
February 12 2018
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Good Shepherd Hospital
Siteki, Lubombo Region, Eswatini
2
Siphofaneni
Siteki, Lubombo Region, Eswatini
3
Siteki PHU
Siteki, Lubombo Region, Eswatini
4
Family Life Association Clinic
Manzini, Eswatini